4//SEC Filing
Reardon Andrew 4
Accession 0002001011-25-000010
CIK 0000886163other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:37 PM ET
Size
12.1 KB
Accession
0002001011-25-000010
Insider Transaction Report
Form 4
Reardon Andrew
CLO & Secretary
Transactions
- Award
Common Stock
2025-02-14+6,928→ 29,462 total - Tax Payment
Common Stock
2025-02-14$120.00/sh−2,775$333,000→ 26,687 total - Award
Common Stock
2025-02-14+5,429→ 32,116 total - Tax Payment
Common Stock
2025-02-14$120.00/sh−1,758$210,960→ 30,358 total - Tax Payment
Common Stock
2025-02-15$120.00/sh−1,114$133,680→ 29,244 total - Tax Payment
Common Stock
2025-02-15$120.00/sh−876$105,120→ 28,368 total
Footnotes (3)
- [F1]Represents shares of common stock issued upon the vesting and certification of performance stock units (PSUs).
- [F2]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of performance stock units.
- [F3]Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.
Documents
Issuer
LIGAND PHARMACEUTICALS INC
CIK 0000886163
Entity typeother
Related Parties
1- filerCIK 0001950232
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:37 PM ET
- Size
- 12.1 KB